Powder: -20°C for 3 years | In solvent: -80°C for 1 year
12-OxoETE is synthesized by human platelets and Aplysia nervous tissue after incubation with arachidonic acid. Microsomal fractions of various tissues will reduce 12-oxoETE to 12(S)-HETE or a mixture of 12(S)- and 12(R)-HETE. 12-OxoETE induces a rapid, dose dependent increase of cytoplasmic free calcium via a leukotriene B4 receptor or a common activation sequence.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 μg | 35 days | $ 328.00 | |
50 μg | 35 days | $ 615.00 | |
100 μg | 35 days | $ 1,160.00 | |
250 μg | 35 days | $ 2,570.00 |
Description | 12-OxoETE is synthesized by human platelets and Aplysia nervous tissue after incubation with arachidonic acid. Microsomal fractions of various tissues will reduce 12-oxoETE to 12(S)-HETE or a mixture of 12(S)- and 12(R)-HETE. 12-OxoETE induces a rapid, dose dependent increase of cytoplasmic free calcium via a leukotriene B4 receptor or a common activation sequence. |
Molecular Weight | 318.457 |
Formula | C20H30O3 |
CAS No. | 108437-64-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMF: Miscible
PBS (pH 7.2): 0.8 mg/mL
Ethanol: Miscible
DMSO: Miscible
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
12-OxoETE 108437-64-5 12OxoETE 12 OxoETE inhibitor inhibit